期刊
PSYCHIATRY AND CLINICAL NEUROSCIENCES
卷 72, 期 3, 页码 152-159出版社
WILEY
DOI: 10.1111/pcn.12637
关键词
Alzheimer's disease; amyloid beta clearance; neuroprotection; oligomeric amyloid hypothesis; rifampicin
Rifampicin exerts significant brain protective functions in multiple experimental models. Here we summarize the underlying mechanisms of the neuroprotective and pro-cognitive effects of rifampicin that are mediated by its anti-inflammatory, anti-tau, anti-amyloid, and cholinergic effects. Beyond suggesting that rifampicin shows strong brain protective effects in preclinical models of Alzheimer's disease, we also provide substantial clinical evidence for the neuroprotective and procognitive effects of rifampicin. Future neuroimaging studies combined with clinical assessment scores are the following steps to be taken in this field of research.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据